Search research articles
Contact Us
Filters
Showing results (11-20 of 19) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 19 results.
Clinical Nuclear Medicine
|
November 1, 1982
Diagnosis of non-Hodgkin's lymphoma intracerebral mass lesions. Usefulness of Tc-99m pertechnetate and Ga-67 citrate brain scans
B L Zidar, M Adatepe, F Hryschko, et al.
Investigational New Drugs
|
September 1, 1988
A phase II evaluation of cisplatin in unresectable diffuse malignant mesothelioma: a Southwest Oncology Group Study
B L Zidar, S Green, H I Pierce, et al.
Cancer
|
November 15, 1992
A phase II evaluation of ifosfamide and mesna in unresectable diffuse malignant mesothelioma. A Southwest Oncology Group study
B L Zidar, B Metch, S P Balcerzak, et al.
Cancer
|
August 1, 1990
ViVACCy--a drug schedule based on G2 blockade and prolonged infusion of multiple tubulin-binding agents. A pilot study
S E Shackney, R P Pugh, B L Zidar, et al.
Cancer
|
November 15, 1983
Treatment of six cases of mesothelioma with doxorubicin and cisplatin
B L Zidar, R P Pugh, L M Schiffer, et al.
American Journal of Clinical Pathology
|
April 1, 1987
Pseudo-Gaucher cells in the bone marrow of a patient with Hodgkin's disease
B L Zidar, R J Hartsock, R E Lee, et al.
British Journal of Haematology
|
December 1, 1977
Hairy cell leukaemia: seven cases with probable B-lymphocytic origin
B L Zidar, A Winkelstein, T L Whiteside, et al.
Cancer
|
September 15, 1987
Radiation-induced leiomyosarcoma of the great vessels presenting as superior vena cava syndrome
K S Weiss, B L Zidar, S Wang, et al.
Cancer
|
April 1, 1995
Decline of posttreatment tumor marker levels after therapy of nonsmall cell lung cancer. A useful outcome predictor
C H Spiridonidis, L R Laufman, K A Stydnicki, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 19) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 19 results.
Clinical Nuclear Medicine
|
November 1, 1982
Diagnosis of non-Hodgkin's lymphoma intracerebral mass lesions. Usefulness of Tc-99m pertechnetate and Ga-67 citrate brain scans
B L Zidar, M Adatepe, F Hryschko, et al.
Investigational New Drugs
|
September 1, 1988
A phase II evaluation of cisplatin in unresectable diffuse malignant mesothelioma: a Southwest Oncology Group Study
B L Zidar, S Green, H I Pierce, et al.
Cancer
|
November 15, 1992
A phase II evaluation of ifosfamide and mesna in unresectable diffuse malignant mesothelioma. A Southwest Oncology Group study
B L Zidar, B Metch, S P Balcerzak, et al.
Cancer
|
August 1, 1990
ViVACCy--a drug schedule based on G2 blockade and prolonged infusion of multiple tubulin-binding agents. A pilot study
S E Shackney, R P Pugh, B L Zidar, et al.
Cancer
|
November 15, 1983
Treatment of six cases of mesothelioma with doxorubicin and cisplatin
B L Zidar, R P Pugh, L M Schiffer, et al.
American Journal of Clinical Pathology
|
April 1, 1987
Pseudo-Gaucher cells in the bone marrow of a patient with Hodgkin's disease
B L Zidar, R J Hartsock, R E Lee, et al.
British Journal of Haematology
|
December 1, 1977
Hairy cell leukaemia: seven cases with probable B-lymphocytic origin
B L Zidar, A Winkelstein, T L Whiteside, et al.
Cancer
|
September 15, 1987
Radiation-induced leiomyosarcoma of the great vessels presenting as superior vena cava syndrome
K S Weiss, B L Zidar, S Wang, et al.
Cancer
|
April 1, 1995
Decline of posttreatment tumor marker levels after therapy of nonsmall cell lung cancer. A useful outcome predictor
C H Spiridonidis, L R Laufman, K A Stydnicki, et al.
Page
of 2